The initial findings of the first biopharma league table have been unveiled by bioLIVE —the new bioprocessing and manufacturing event running alongside CPhI Worldwide — ranking the US at the top and China at the bottom. more


Tech company, Univercells, and Global Health Investment Fund (GHIF) have announced the closing of a €16 million Series B equity financing round, which will support the continued development of Univercell’s biomanufacturing technology. more


A report from bioLIVE has forecasted that outsourcing will play an increasing role in the bio supply chain and that continuous manufacturing, API and process analytical technology (PAT) expertise will be vital to future growth. more


A partnership has been formed between Horizon Discovery Group and The Pirbright Institute to cover collaborative work on a research programme aimed at deploying cell engineering to increase vaccine yields for livestock. more


Univercells, a company dedicated to delivering biomanufacturing solutions, has received a grant from the Walloon Region in Belgium that will be used to develop an antibody production platform. more


In this article Steve Lam, senior vice president and head of biologics, Patheon, looks at which choice is best when developing a biomanufacturing strategy. more


The Austrian Centre of Industrial Biotechnology and pharmaceutical company GE Healthcare have announced a cell line engineering research collaboration in an attempt to bring increased productivity to biomanufacturers. more